MedTrace Logo

Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE

NCT00755066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2008-09-26

No results posted yet for this study

Summary

Evaluation of the effect of fluticasone propionate vs placebo applied as nasal spray on the increase of allergen-specific serum IgE levels following nasal exposure to recombinant allergens. Nasal sprays will be applied for four weeks starting two weeks before nasal provocation and serum IgE levels will be followed during eight weeks after nasal provocation.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DRUG

Fluticasone propionate

200 µg intranasal, 4 weeks, od.

DRUG

Placebo

Placebo intranasal spray

Sponsors & Collaborators

  • Allergy Centre Vienna West

    collaborator OTHER

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Friedrich Horak, MD · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Austria

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00755066 on ClinicalTrials.gov